Primary Recipient

UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE, INC.

Amount

$86,461.00

Award Date

1/30/2012

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

We have found that SPRY2, a key regulator of RTK to ERK signaling, is absent in about 1/3 of a small set of ovarian cancers we have investigated. We propose to test whether levels of SPRY2 predict survival of women with advanced ovarian cancer who have be